Lila Sciences, an AI startup focused on building ‘scientific superintelligence,’ is closing in on a Series A funding round of $300 million or more, signaling strong investor interest in leveraging AI to accelerate scientific discovery. Lila’s platform aims to automate complex scientific research processes autonomously. This substantial capital raise would empower the company to expand its technology and scale its operations. The development represents a significant infusion into AI-driven biotech innovation.